Search Results
204 items found for "Systemic treatment"
- Fentanyl activates ovarian cancer and alleviates chemotherapy-induced toxicity via opioid...
Proliferation, migration and apoptosis assays were performed in ovarian cancer cells after fentanyl treatment
- Anatomy of a partnership: Cancer Research UK teams up with Sosei Heptares
August 2022 "August 10, 2022 Cancer Research UK is working with global biopharma Sosei Heptares on a treatment
- Signaling pathways activated by sea bass gonadotropin-inhibitory hormone peptides in COS-7 cells...
studies provided evidence for the existence of a functional gonadotropin-inhibitory hormone (GnIH) system
- Role of G Protein-Coupled Receptors in Hepatic Stellate Cells and Approaches to Anti-Fibrotic ...
Role of G Protein-Coupled Receptors in Hepatic Stellate Cells and Approaches to Anti-Fibrotic Treatment expressed in HSCs, their roles in liver fibrogenesis, and finally speculate on the development of novel treatments
- Rescue of Cell Surface Expression and Signaling of Mutant Follicle-Stimulating Hormone Receptors
expression was determined by enzyme-linked immunosorbent assay of epitope-tagged FSHRs before/after treatment with severely reduced cell surface expression, restoration to ≥57% of WT levels was achieved for 6 by treatment
- The development of modulators for lysophosphatidic acid receptors: A comprehensive review
have entered phase Ⅱ clinical trials for idiopathic pulmonary fibrosis (BMS-986020 and BMS-986278) and systemic
- GPCRs are not simple on-off switches: deep dive into GPCR-ligand interactions
proteins, and the disruption of natural spatial and temporal signaling patterns regulated by physiological systems processes like neurotransmission and chemokine signaling, extending to numerous other GPCR-regulated systems
- Fly casting with ligand sliding and orientational selection supporting complex formation of a GPCR..
complex formation of a GPCR and a middle sized flexible molecule "A GA-guided multidimensional virtual-system
- Isoforms of GPR35 have distinct extracellular N-termini that allosterically modify...
therapies against, for example, inflammatory bowel disease or bacterial infections of the gastrointestinal system
- Crinetics Presents Clinical And Research Results At ENDO 2022
results from the company’s Phase 1 study of CRN04894, the company’s investigational candidate for the treatment
- The expression and clinical significance of GPR39 in colon cancer
Colorectal cancer is the third most common cancer and requires more prognostic biomarkers for precise treatment
- Viral G Protein-Coupled Receptors Encoded by β- and γ-Herpesviruses
Finally, we briefly discuss the therapeutic targeting of vGPCRs as future treatment of acute and chronic
- Exscientia is 10 years old this July!
enter clinical trials, the first AI-driven precision medicine platform clinically validated to guide treatment
- Co-activation of GPCRs facilitate GIRK-dependent current
Results demonstrate that the activity of either G protein-coupled receptor system must be considered
- Hear the sounds: the role of G protein-coupled receptors in the cochlea
the cochlea is essential for the understanding of the cochlea development, hearing disorders, and the treatment
- 📰 GPCR Weekly News, October 16 to 22, 2023
targeting intracellular allosteric sites of GPCRs for drug discovery Targeting mGluR group III for the treatment Domain Therapeutics, Presents Groundbreaking Advancements at ESMO 2023 Novo Nordisk to Buy Hypertension Treatment
- Addex Therapeutics Completes Patient Enrollment For Dipraglurant Blepharospasm Phase 2 Clinical ...
enrollment has been completed in its Phase 2a clinical study evaluating dipraglurant as a potential treatment
- Deficiency of β-arrestin2 alleviates apoptosis through GRP78-ATF6-CHOP signaling pathway in ...
etiology of primary Sjögren's syndrome (pSS) remains unknown, and there is no ideal drug for the specific treatment underlying role of β-arrestin2 and provided an experimental foundation for β-arrestin2 depletion in the treatment
- Deciphering the signaling mechanisms of β-arrestin1 and β-arrestin2 in regulation of cancer cell...
Understanding these processes has important implications for understanding the therapeutic intervention and treatment
- Ligands can differentially and temporally modulate GPCR interaction with 14-3-3 isoforms
exist, and a GPCR can differentially interact with different 14-3-3 isoforms in response to agonist treatment
- Case Report of a Juvenile Patient with Autism Spectrum Disorder with a Novel Combination of Copy...
The patient described in the present study showed increased symptoms under methylphenidate treatment
- Deciphering the signaling mechanisms of β-arrestin1 and β-arrestin2 in regulation of cancer cell...
Understanding these processes has important implications for understanding the therapeutic intervention and treatment
- In vivo detection of GPCR-dependent signaling using fiber photometry and FRET-based biosensors
biosensors, we were able to track GPCR-dependent signaling pathways over time, and in response to drug treatments
- CCL25/CCR9 interaction promotes the malignant behavior of salivary adenoid cystic carcinoma via...
vivo was examined by a xenograft tumor model in nude mice following CCL25, Vercirnon and LY294002 treatment
- 📰 GPCR Weekly News, July 31 to August 6, 2023
Nichola J Smith's investigation: Gene expression of TAS1R taste receptors for cardiometabolic disease treatment Cardiology, Endocrinology, and Taste Gene expression analyses of TAS1R taste receptors relevant to the treatment
- Neurocrine Biosciences Announces Positive Phase 3 Data for KINECT-HD Study Evaluating Valbenazine...
a selective vesicular monoamine transporter 2 (VMAT2) inhibitor being investigated as a once-daily treatment
- 📰 Breaking Down the Latest GPCR Discoveries: a Weekly Update (Nov 27-Dec 3, 2023)
selective adrenomedullin analogs Novel multi-target ligands of dopamine and serotonin receptors for the treatment into Definitive Merger Agreement with Roche New Clinical Trial Explores Novel Target In Parkinson’s Treatment
- Positive Recommendation for Use of TAVNEOS™ (avacopan) in ANCA Vasculitis Adopted by European ...
receptor inhibitor, in combination with a rituximab or cyclophosphamide regimen, indicated for the treatment